Literature DB >> 24766545

Renal nerve ablation for resistant hypertension: the dust has not yet settled.

Michael Doumas1, Antonios Lazaridis, Vasilios Papademetriou.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24766545      PMCID： PMC8031765          DOI： 10.1111/jch.12324

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  27 in total

1.  Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.

Authors:  Murray D Esler; Henry Krum; Paul A Sobotka; Markus P Schlaich; Roland E Schmieder; Michael Böhm
Journal:  Lancet       Date:  2010-11-17       Impact factor: 79.321

2.  Interventional management of resistant hypertension.

Authors:  Michael Doumas; Stella Douma
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321

Review 3.  Clinical studies of renal nerve ablation. Unanswered questions for its efficacy and safety.

Authors:  Doumas Michalis; C Faselis; P Kokkinos; Tsioufis Costas; Papademetriou Vasilios
Journal:  Curr Clin Pharmacol       Date:  2013-08

4.  Aerobic exercise reduces blood pressure in resistant hypertension.

Authors:  Fernando Dimeo; Nikolaos Pagonas; Felix Seibert; Robert Arndt; Walter Zidek; Timm H Westhoff
Journal:  Hypertension       Date:  2012-07-16       Impact factor: 10.190

5.  Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring.

Authors:  Alejandro de la Sierra; Julián Segura; José R Banegas; Manuel Gorostidi; Juan J de la Cruz; Pedro Armario; Anna Oliveras; Luis M Ruilope
Journal:  Hypertension       Date:  2011-03-28       Impact factor: 10.190

6.  Prevalence of resistant hypertension in the United States, 2003-2008.

Authors:  Stephen D Persell
Journal:  Hypertension       Date:  2011-04-18       Impact factor: 10.190

7.  Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial.

Authors:  Eduardo Pimenta; Krishna K Gaddam; Suzanne Oparil; Inmaculada Aban; Saima Husain; Louis J Dell'Italia; David A Calhoun
Journal:  Hypertension       Date:  2009-07-20       Impact factor: 10.190

Review 8.  Unintentional overestimation of an expected antihypertensive effect in drug and device trials: mechanisms and solutions.

Authors:  James P Howard; Graham D Cole; Horst Sievert; Deepak L Bhatt; Vasilios Papademetriou; David E Kandzari; Justin E Davies; Darrel P Francis
Journal:  Int J Cardiol       Date:  2014-01-08       Impact factor: 4.164

9.  Renal sympathetic denervation: early impact on ambulatory resistant hypertension.

Authors:  Marius Schwerg; Christian Heupel; Dino Strajnic; Gert Baumann; Michael Laule; Verena Stangl; Karl Stangl
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-04-28       Impact factor: 3.738

10.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

Authors:  Henry Krum; Markus Schlaich; Rob Whitbourn; Paul A Sobotka; Jerzy Sadowski; Krzysztof Bartus; Boguslaw Kapelak; Anthony Walton; Horst Sievert; Suku Thambar; William T Abraham; Murray Esler
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321
View more
  1 in total

1.  Renal sympathetic denervation: Ashes to ashes or rebirth from the ashes?

Authors:  Michael Doumas; Konstantinos Stavropoulos; Konstantinos P Imprialos; Vasilios G Athyros; Asterios Karagiannis
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-25       Impact factor: 3.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.